Nov 7 (Reuters) - Adalta Ltd 1AD.AX :
* Co and XL-Protein GMBH entered into a collaboration on development and commercialization of a long acting form of AD-114
* Under the agreement XL-Protein will apply its proprietary pasylation technology to ad-114 to extend its circulation half-life Source text for Eikon: ID:nASX8HnXhR Further company coverage: 1AD.AX